|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas 显示文摘 | Zelenetz AD Abramson JS Advani RH | 2010 | J Natl Compr Canc Netw2010，8，3： | 1 |
| 2 | Pivotal study of iodine I131 tositumomab for chemotherapy-refractory low-grade or transformedlow-grade B-cell non-Hodgkin's lymphomas显示文摘 | Kaminski MS Zelenetz AD Press OW | 2001 | J Clin Oncol2001，19，19： | 1 |
| 3 | NCCN non-Hodgkin's lymphoma practice guidelines panel显示文摘 | Zelenetz AD Hoppe RT | 2001 | Cancer Control2001，8，612： | 1 |
| 4 | Hepatitis B virus management to prevent reactivation after chemotherapy : a review 显示文摘 | Hwang JP Vierling JM Zelenetz AD | 2012 | Support Care Cancer2012，20，1： | 1 |
| 5 | Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL显示文摘 | Moskowitz CH Zelenetz AD Kewalramani T | 2005 | Blood2005，106，10： | 1 |
| 6 | Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma显示文摘 | Kewalramani T Zelenetz AD Nimer SD | 2004 | Blood2004，103，10： | 1 |
| 7 | High- dose chemoradiotherapy and autologous stem cell transplantation for patients with primary refractory aggressive non- Hodgkin s lymphoma:an intention- to- treat analysis 显示文摘 | Zelenetz AD Hedrick EE | 2000 | Blood2000，96，7： | 1 |
| 8 | Hepatitis B virus management to prevent reactivation after chemotherapy:A review显示文摘 | Hwang JP Vierling JM Zelenetz AD | 2012 | Supportive care in cancer2012，20，11： | 1 |
| 9 | 2-step comprehensive high-dose chemoradiothcrapy second-line program for relapsed and re- fractory Hodgkin disease: Analysis by intent to treat and development of a prognostic model 显示文摘 | Moskowitz CH Nimer SD Zelenetz AD | 2001 | Blood2001，97，3： | 1 |
| 10 | Ifosfamide,carboplatin,etoposide(ICE) based second line chemotherapy for the management of relapsed and refractor 5,aggressive non-Hodgkin lymphoma显示文摘 | Zelenetz AD Hamlin P Kewalramani T | 2003 | Ann Oncol2003，14，： | 1 |
| 11 | Age-adjusted international prognostic index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma显示文摘 | Hamlin PA Zelenetz AD Kewalramani T | 2003 | Blood2003，102，6： | 1 |
| 12 | Rituximab and DICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphomas显示文摘 | Kewalramani T Zelenetz AD Nimer SD | | 0，，10： | 1 |
| 13 | Rituximab and ICE as second Line therapy before autologous stem cell transplantation for primary refrantory diffuse large B cell lymphoma显示文摘 | Kewa Iramani T Zelenetz AD Nimer SD | 2004 | Blood2004，103，10： | 1 |
| 14 | NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin' s lymphomas 显示文摘 | Zelenetz AD Abramson JS Advani RH | 2010 | J Natl Compr Canc Netw2010，8，3： | 1 |
| 15 | NCCN task force report: molecular markers in leukemias and lymphomas显示文摘 | Radich JP Zelenetz AD Chan WC | 2009 | J Natl Compr Canc Netw2009，74，： | 1 |
| 16 | Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL显示文摘 | Moskowitz CH Zelenetz AD Kewalramani T | 2005 | Blood2005，106，： | 1 |
| 17 | Rituximab and ICEas second-line therapy before autologous stem cell transplantation forrelapsed or primary refractory diffuse large B-cell lymphoma显示文摘 | Kewalramani T Zelenetz AD Nimer SD | 2004 | Blood2004，103，10： | 1 |
| 18 | Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma 显示文摘 | Kewalramani T Zelenetz AD Nimer SD | 2004 | Blood2004，103，10： | 1 |
| 19 | NCCN Clinical Practice Guideline in Oneology: non-Hodgkin's lympho- mas 显示文摘 | ZELENETZ AD ABRAMSON JS ADVANI RH | 2012 | J Natl Compr Canc Netw2012，，： | 1 |
| 20 | Non-Hodgkin' s lymphomas, version 4,2014显示文摘 | Zelenetz AD Gordon LI Wierda WG | 2014 | J Natl Compr Canc Netw2014，12，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员